Regulus Therapeutics Is A Biopharmaceutical Company Dedicated To Discovering And Developing Innovative Medicinesparticularly In The Field Of Oligonucleotide Therapeuticsfounded In September 2007 As A Joint Venture Between Alnylam Pharmaceuticals And Isis Pharmaceuticalsthe Company Is Headquartered In Carlsbadcaliforniait Focuses On Pioneering Microrna Therapeutics To Address Diseases With High Unmet Medical Needs The Company Specializes In Creating Novel Oligonucleotide Therapeutics That Target Dysregulated Micrornathese Therapies Aim To Improve The Lives Of Patients Suffering From Serious Diseasesregulus Therapeutics Is Committed To Scientific Rigor And Innovationwith A Mission Centered On Developing Impactful Treatmentsin April 2025The Company Announced An Agreement To Be Acquired By Novartis Agmarking A Significant Milestone In Its Corporate Journey
